Apoptosis of inflammatory cells in immune control of the nervous system: Role of Glia

GLIA

Volumn 36, Issue 2, 2001, Pages 137-144

  Pender, Michael P ^a,b   Rist, Michael J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Astrocyte; Experimental autoimmune encephalomyelitis; Microglia; Multiple sclerosis; T cell

Indexed keywords

ANIMAL; APOPTOSIS; ARTICLE; CENTRAL NERVOUS SYSTEM; ENCEPHALITIS; GLIA; HUMAN; IMMUNOLOGY; METABOLISM; NERVE CELL; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM; ENCEPHALITIS; HUMANS; NEUROGLIA; NEURONS; T-LYMPHOCYTES;

EID: 0035157681     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.1103     Document Type: Article

References (90)

1. Fas ligand mediates activation-induced cell death in human T lymphocytes
2. Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation
3. Death receptors: Signaling and modulation
4. Impairment of TNF-receptor-1 signaling but not Fas signaling diminishes T-cell apoptosis in myelin oligodendrocyte glycoprotein peptide-induced chronic demyelinating autoimmune encephalomyelitis in mice
5. Apoptosis of T lymphocytes in coronavirus-induced encephalomyelitis
6. T-cell apoptosis in inflammatory brain lesions: Destruction of T cells does not depend on antigen recognition
7. FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: Evidence for the existence of an immunological brain barrier
8. L
9. Cell death during autoimmune demyelination: Effector but not target cells are eliminated by apoptosis
10. Nitric oxide and its role in apoptosis
11. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas
12. Phagocytosis of apoptotic inflammatory cells by microglia and modulation by different cytokines: Mechanism for removal of apoptotic cells in the inflamed nervous system
13. Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-α, or IFN-γ
14. Failure to suppress the expansion of the activated CD4 T cell population in interferon γ-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis
15. CD28 can promote T cell survival through a phosphatidylinositol 3-kinase-independent mechanism
16. Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2
17. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
18. Evidence for Fas-dependent and Fas-independent mechanisms in the pathogenesis of experimental autoimmune encephalomyelitis
19. Neuronal FasL induces cell death of encephalitogenic T lymphocytes
20. Microglia induce CD4 T lymphocyte final effector function and death
21. Antigen presentation and tumor cytotoxicity by interferon-γ-treated microglial cells
22. Modulation of Fas-Ligand (Fas-L) on human microglial cells: An in vitro study
23. Antigen presentation by astrocytes primes rat T lymphocytes for apoptotic cell death: A model for T-cell apoptosis in vivo
24. Rapid entry and downregulation of T cells in the central nervous system during the reinduction of experimental autoimmune encephalomyelitis
25. CD3-mediated apoptosis of human medullary thymocytes and activated peripheral T cells: Respective roles of interleukin-1, interleukin-2, interferon-γ and accessory cells
26. Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone
27. T-lymphocyte entry into the central nervous system
28. The susceptibility of mice to immune-mediated neurologic disease correlates with the degree to which their lymphocytes resist the effects of brain-derived gangliosides
29. Soluble antigen therapy induces apoptosis of autoreactive T cells preferentially in the target organ rather than in the peripheral lymphoid organs
30. Role of passive T-cell death in chronic experimental autoimmune encephalomyelitis
31. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation
32. Coexpression of Fas/FasL and Bax on brain and infiltrating T cells in the central nervous system is closely associated with apoptotic cell death during autoimmune encephalomyelitis
33. Interaction between apoptotic cells and reactive brain cells in the central nervous system of rats with autoimmune encephalomyelitis
34. Unimpaired autoreactive T-cell traffic within the central nervous system during tumor necrosis factor receptor-mediated inhibition of experimental autoimmune encephalomyelitis
35. Differential regulation and function of Fas expression on glial cells
36. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
37. Interferon γ plays a critical role in induced cell death of effector T cell: A possible third mechanism of self-tolerance
38. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
39. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids
40. Myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis is chronic/relapsing in perforin knockout mice, but monophasic in Fas- and Fas ligand-deficient lpr and gld mice
41. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals
42. A very high level of crossreactivity is an essential feature of the T-cell receptor
43. Immunohistochemical analysis of the rat central nervous system during experimental allergic encephalomyelitis, with special reference to Ia-positive cells with dendritic morphology
44. Immune regulation by brain cells in the central nervous system: Microglia but not astrocytes present myelin basic protein to encephalitogenic T cells under in vivo-mimicking conditions
45. In situ inactivation of infiltrating T cells in the central nervous system with autoimmune encephalomyelitis. The role of astrocytes
46. + T lymphocytes in the spinal cord during recovery from experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein
47. + cells
48. IL-2 rescues antigen-specific T cells from radiation or dexamethasone-induced apoptosis: Correlation with induction of Bcl-2
49. + helper T cells: A model for the long-term survival of memory cells
50. Phagocytosis of apoptotic lymphocytes by oligodendrocytes in experimental autoimmune encephalomyelitis
51. Macrophage apoptosis in the central nervous system in experimental autoimmune encephalomyelitis
52. Increased apoptosis of T lymphocytes and macrophages in the central and peripheral nervous systems of Lewis rats with experimental autoimmune encephalomyelitis treated with dexamethasone
53. IL-2 protects T lymphocytes from glucocorticoid-induced DNA fragmentation and cell death
54. In situ demonstration of proliferating cells in the rat central nervous system during experimental autoimmune encephalomyelitis: Evidence suggesting that most infiltrating T cells do not proliferate in the target organ
55. Fas has a crucial role in the progression of experimental autoimmune encephalomyelitis
56. Genetically determined failure of activation-induced apoptosis of autoreactive T cells as a cause of multiple sclerosis
57. Activation-induced apoptosis of autoreactive and alloreactive T lymphocytes in the target organ as a major mechanism of tolerance
58. Apoptosis in the nervous system in experimental allergic encephalomyelitis
59. Apoptosis of αβ T lymphocytes in the nervous system in experimental autoimmune encephalomyelitis: Its possible implications for recovery and acquired tolerance
60. Surges of increased T cell reactivity to an encephalitogenic region of myelin proteolipid protein occur more often in patients with multiple sclerosis than in healthy subjects
61. Apoptosis within spontaneously accepted mouse liver allografts: Evidence for deletion of cytotoxic T cells and implications for tolerance induction
62. Apoptosis: The importance of being eaten
63. Receptor-stimulated death pathway is opened by antigen in mature T cells
64. Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system
65. Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis
66. T-cell apoptosis in situ in experimental autoimmune encephalomyelitis following methylprednisolone pulse therapy
67. Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis: Evidence for programmed cell death as a mechanism to control inflammation in the brain
68. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production
69. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures
70. Apoptosis of T cells and macrophages in the central nervous system of intact and adrenalectomized Lewis rats during experimental allergic encephalomyelitis
71. Expression of Ia antigen on perivascular and microglial cells after sublethal and lethal motor neuron injury
72. Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions
73. Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis
74. + encephalitogenic T cells
75. Antigen-specific down-regulation of myelin basic protein-reactive T cells during spontaneous recovery from experimental autoimmune encephalomyelitis: Further evidence of apoptotic deletion of autoreactive T cells in the central nervous system
76. Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-γ-activated SJL/J astrocytes
77. Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis
78. Molecular mechanisms of high-dose antigen therapy in experimental autoimmune encephalomyelitis: Rapid induction of Th1-type cytokines and inducible nitric oxide synthase
79. Cellular immune reactivity within the CNS
80. Systemic immune deviation in the brain that does not depend on the integrity of the blood-brain barrier
81. Microglia are more susceptible than macrophages to apoptosis in the central nervous system in experimental autoimmune encephalomyelitis through a mechanism not involving Fas (CD95)
82. The roles of Fas, Fas ligand and Bcl-2 in T cell apoptosis in the central nervous system in experimental autoimmune encephalomyelitis
83. B cell apoptosis in the central nervous system in experimental autoimmune encephalomyelitis: Roles of B cell CD95, CD95L and Bcl-2 expression
84. A targeted DNA vaccine encoding Fas ligand defines its dual role in the regulation of experimental autoimmune encephalomyelitis
85. Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein
86. Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: Inhibition of Fas ligand expression by retinoic acid and glucocorticoids
87. Programmed T lymphocyte death: Cell activation- and steroid-induced pathways are mutually antagonistic
88. + T cells as a mechanism for remission from experimental allergic encephalomyelitis
89. Apoptosis of myelin-reactive T cells induced by reactive oxygen and nitrogen intermediates in vitro
90. Dual effect of glucocorticoids on apoptosis of human autoreactive and foreign antigen-specific T cells